Sangamo Therapeutics, Inc. (SGMO)
0.366
-0.04
(-8.82%)
USD |
NASDAQ |
Jan 20, 16:00
0.38
+0.01
(+3.83%)
Pre-Market: 09:17
Sangamo Therapeutics EPS Diluted (Quarterly): -0.1148 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.93M |
| Revenue (Quarterly) | 0.581M |
| Total Expenses (Quarterly) | 35.51M |
| Enterprise Value | 118.05M |
| Gross Profit Margin (Quarterly) | -226.7% |
| Profit Margin (Quarterly) | -6.01K% |
| Earnings Yield | -121.0% |
| Normalized Earnings Yield | -121.12 |